Clinical Trials Browser

Phase 3 × Saline Solution × Gastrointestinal × Clear all

NCT06807437 2026-03-31

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Phase 3 Recruiting

274 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03085004 2026-03-30

CHARM

Phase 3 Terminated

75 enrolled

Gastrointestinal

Pancreatic Cyst

NCT03221426 2026-03-09

KEYNOTE-585

Phase 3 Completed

1,007 enrolled 25 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT04882241 2026-03-06

KEYNOTE-585

Phase 3 Completed

120 enrolled 17 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT06910514 2025-04-09

Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions

Phase 3 Completed

52 enrolled

Gastrointestinal

Colonic Neoplasms

NCT04210115 2024-11-15

KEYNOTE 975

Phase 3 Active not recruiting

703 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

NCT01956812 2021-08-16

PANCRIT®-1

Phase 3 Terminated

334 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03780049 2020-05-21

HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B

Phase 3 Unknown

304 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT02987907 2016-12-09

The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.

Phase 3 Unknown

220 enrolled

Gastrointestinal

Carcinoma, Hepatocellular